| KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES Patent applications |
| Patent application number | Title | Published |
|---|
| 20120034235 | Marker for Liver-Cancer Diagnosis and Recurrence and Survival Prediction, a Kit Comprising the Same, and Prognosis Prediction in Liver-Cancer Patients Using the Marker - A composition for detecting a marker for the diagnosis or prognosis of liver cancer is disclosed. The composition includes an agent capable of assessing the expression level of UQCRH (ubiquinol-cytochrome c reductase hinge protein). In addition, a kit having the composition, a microarray for the diagnosis of liver cancer using the marker, and a method for detecting the marker, and predicting recurrence following surgery in liver cancer patients are disclosed. The marker is able to contribute to the early diagnosis of liver cancer and prediction of recurrence following surgery and survival of liver cancer patients who have undergone hepatic resection, and also is significant for being a promising therapeutic target for liver cancer. | 02-09-2012 |
| 20110046086 | Composition Comprising Polysaccharide Extracted from Panax Ginseng Preventing and Treating Liver Diseases - The present disclosure relates to a | 02-24-2011 |
| 20100304409 | METHOD FOR DETECTING PREMATURE SENESCENCE IN TUMOR CELLS AND A KIT FOR DETECTING PREMATURE SENESCENCE IN TUMOR CELLS - The present invention provides a method for detecting senescence in tumor cells and a kit for detecting senescence in tumor cells. eEF1A1 and CD markers are provided, wherein changes in the levels of the markers are correlated with premature senescence of tumor cells. | 12-02-2010 |
| 20100294655 | RADIOISOTOPE PRODUCTION O-18 WATER TARGET HAVING IMPROVED COOLING PERFORMANCE - A target apparatus for producing a radioisotope having improved cooling performance including a cavity member including a cavity accommodating H | 11-25-2010 |
| 20100233758 | Protein increasing cell infectivity of herpes simplex virus and use thereof - Provided are an isolated protein derived from an N-terminal of HveA/HVEM and having activity of increasing the cell infectivity of herpes simplex virus (HSV) and use thereof. | 09-16-2010 |
| 20100180632 | PILEUS-GILLS TYPE HELIUM CONDENSER AND APPARATUS INCLUDING THE SAME - Provided are a pileus-gills type helium condenser and an apparatus, including the same, for condensing helium. The pileus-gills type helium condenser includes: a body having a hemispheric shape and formed of a highly thermally conductive metal; a plurality of cooling fins collectively having a pileus gills-like shape and arranged along the circumference of the body to be spaced apart from one another; and a through-hole formed in the center of the body to be adjacent to the cooling fins. | 07-22-2010 |
| 20100119443 | RADIOTHERAPEUTIC SYSTEM AND METHOD PERFORMED BY NON-INVASIVE AND REAL-TIME TUMOR POSITION TRACKING - A radiotherapeutic system including non-invasive and real-time tumor tracking includes: a signal detector for detecting radioactive rays emitted from a tumor to which the radioactive medical supply is adsorbed and generating an electrical signal; a signal processor for converting the electrical signal generated into a three-dimensional (3D) coordinate signal; a controller for generating a control signal in conjunction with the 3D coordinate signal output by the signal processor; and a radioactive-ray irradiation device for emitting radioactive rays to the tumor, wherein the amount of the radioactive rays is controlled by the controller. | 05-13-2010 |
| 20100098671 | COMPOSITION FOR PREVENTION OR TREATMENT OF BONE MARROW DAMAGE - Disclosed herein are a composition for prevention or treatment of bone marrow damage comprising Substance-P as an active ingredient; a use of Substance-P for the preparation of a medicament for prevention or treatment of bone marrow damage; a method for prevention or treatment of bone marrow damage comprising administering a therapeutically effective amount of Substance-P to a mammal; an anticancer supplement comprising Substance-P as an active ingredient; a use of Substance-P for the preparation of an anticancer supplement; and a method for prevention or treatment of cancer comprising administering a therapeutically effective amount of Substance-P as an anticancer supplement to a mammal. | 04-22-2010 |
| 20090220046 | COLLIMATOR DEVICE FOR RADIOTHERAPY AND RADIOTHERAPY APPARATUS USING THE SAME - Provided is a collimator device for radiotherapy including: a body including a first through unit and disposed on a path of high energy radiation which in use is irradiated toward a patient's treatment part; a frame including a through hole corresponding to the first through unit and slidably installed in the body; a plurality of multi-leaf collimators (MLCs) slidably installed in the through hole and including radiation shields; a servo motor coupled to the body and the frame in a power manner so as to slidingly move the frame with respect to the body; and a motor controller externally receiving position displacement data regarding a motion of the patient's treatment part due to a patient's breathing and generating a signal for controlling the driving of the servo motor so that the MLCs follow the patient's treatment part and continuously apply radiation to the patient's treatment part based on the position displacement data. | 09-03-2009 |
| 20090176888 | COMPOSITION COMPRISING PHYTOSPHINGOSINE OR DERIVATIVE THEREOF - Provided is a composition for cancer treatment including phytosphingosine or a derivative thereof, or a pharmaceutically acceptable salt thereof as an active ingredient. | 07-09-2009 |
| 20090175835 | COMPOSITION FOR TREATING DAMAGE OF CENTRAL OR PERIPHERAL NERVE SYSTEM - The present invention provides a composition for treating damage of central or peripheral nerve system comprising neural precursor cell derived from subcutaneous tissue; neuron obtained by differentiating the neural precursor cell; or oligodendrocyte or Schwann cell obtained by differentiating the neural precursor cell; a use of neural precursor cell derived from subcutaneous tissue, neuron obtained by differentiating the neural precursor cell, or oligodendrocyte or Schwann cell obtained by differentiating the neural precursor cell, for the manufacture of an agent for treating damage of central or peripheral nerve system; a method for treating damage of central or peripheral nerve system which comprises administrating to a mammal a therapeutically effective amount of neural precursor cell derived from subcutaneous tissue, neurons obtained by differentiating the neural precursor cell, or oligodendrocyte or Schwann cell obtained by differentiating the neural precursor cell. Further, the present invention provides a method of preparing the neural precursor cell, neurons, oligodendrocyte or Schwann cell of the present invention. | 07-09-2009 |
